| Primary |
| Rheumatoid Arthritis |
51.1% |
| Psoriasis |
17.8% |
| Psoriatic Arthropathy |
12.6% |
| Product Used For Unknown Indication |
6.7% |
| Ankylosing Spondylitis |
4.9% |
| Drug Use For Unknown Indication |
1.9% |
| Juvenile Arthritis |
1.5% |
| Hypertension |
0.7% |
| Pain |
0.4% |
| Osteoporosis |
0.4% |
| Arthritis |
0.3% |
| Juvenile Idiopathic Arthritis |
0.3% |
| Prophylaxis |
0.3% |
| Osteoarthritis |
0.2% |
| Diabetes Mellitus |
0.2% |
| Systemic Lupus Erythematosus |
0.2% |
| Polyarthritis |
0.2% |
| Depression |
0.1% |
| Spondyloarthropathy |
0.1% |
| Fibromyalgia |
0.1% |
|
| Injection Site Pain |
19.1% |
| Psoriasis |
9.8% |
| Rheumatoid Arthritis |
8.6% |
| Injection Site Swelling |
6.7% |
| Drug Ineffective |
5.4% |
| Pain In Extremity |
5.1% |
| Injection Site Reaction |
5.0% |
| Sinusitis |
4.8% |
| Injection Site Warmth |
4.3% |
| Injection Site Erythema |
4.1% |
| Nasopharyngitis |
3.9% |
| Pain |
3.3% |
| Therapeutic Response Decreased |
3.2% |
| Injection Site Pruritus |
3.0% |
| Headache |
2.5% |
| Injection Site Haematoma |
2.5% |
| Vomiting |
2.2% |
| Arthralgia |
2.2% |
| Pyrexia |
2.1% |
| Nausea |
2.1% |
|
| Secondary |
| Rheumatoid Arthritis |
28.7% |
| Psoriasis |
25.3% |
| Psoriatic Arthropathy |
24.2% |
| Product Used For Unknown Indication |
4.8% |
| Ankylosing Spondylitis |
4.4% |
| Drug Use For Unknown Indication |
2.1% |
| Hypertension |
1.6% |
| Osteoarthritis |
1.3% |
| Juvenile Arthritis |
1.2% |
| Osteoporosis |
1.2% |
| Pain |
0.8% |
| Systemic Lupus Erythematosus |
0.7% |
| Prophylaxis |
0.7% |
| Arthritis |
0.7% |
| Fibromyalgia |
0.7% |
| Sjogren's Syndrome |
0.4% |
| Diabetes Mellitus |
0.4% |
| Gastritis |
0.3% |
| Antibiotic Prophylaxis |
0.3% |
| Depression |
0.3% |
|
| Psoriasis |
23.4% |
| Injection Site Pain |
13.7% |
| Psoriatic Arthropathy |
8.9% |
| Rheumatoid Arthritis |
6.4% |
| Drug Ineffective |
5.4% |
| Pain In Extremity |
4.1% |
| Therapeutic Response Decreased |
3.9% |
| Injection Site Swelling |
3.5% |
| Sinusitis |
3.4% |
| Injection Site Warmth |
3.0% |
| Pain |
2.9% |
| Vomiting |
2.7% |
| Injection Site Erythema |
2.6% |
| Injection Site Reaction |
2.6% |
| Urinary Tract Infection |
2.5% |
| Nasopharyngitis |
2.3% |
| Arthralgia |
2.3% |
| Weight Decreased |
2.2% |
| Weight Increased |
2.1% |
| Pyrexia |
2.1% |
|
| Concomitant |
| Rheumatoid Arthritis |
28.2% |
| Product Used For Unknown Indication |
24.2% |
| Drug Use For Unknown Indication |
9.1% |
| Osteoporosis |
6.9% |
| Psoriasis |
6.6% |
| Hypertension |
4.2% |
| Psoriatic Arthropathy |
3.6% |
| Pain |
2.9% |
| Depression |
2.2% |
| Arthritis |
1.8% |
| Diabetes Mellitus |
1.4% |
| Ankylosing Spondylitis |
1.3% |
| Prophylaxis |
1.2% |
| Blood Cholesterol Increased |
1.0% |
| Hypothyroidism |
1.0% |
| Osteopenia |
0.9% |
| Asthma |
0.9% |
| Anxiety |
0.9% |
| Arthralgia |
0.8% |
| Systemic Lupus Erythematosus |
0.8% |
|
| Weight Decreased |
10.1% |
| Drug Ineffective |
9.0% |
| Rheumatoid Arthritis |
9.0% |
| Vomiting |
6.3% |
| Nausea |
5.9% |
| Psoriasis |
5.9% |
| Urticaria |
5.5% |
| Myocardial Infarction |
5.3% |
| Weight Increased |
5.0% |
| Wound Infection Staphylococcal |
4.8% |
| Urinary Tract Infection |
4.2% |
| Rash |
3.7% |
| Vision Blurred |
3.7% |
| Death |
3.5% |
| Vertigo |
3.5% |
| Pain |
3.3% |
| Fatigue |
3.1% |
| Pneumonia |
2.8% |
| Sinusitis |
2.8% |
| Dyspnoea |
2.6% |
|
| Interacting |
| Rheumatoid Arthritis |
26.4% |
| Drug Use For Unknown Indication |
8.5% |
| Epilepsy |
8.5% |
| Product Used For Unknown Indication |
8.5% |
| Psoriasis |
8.5% |
| Factor Viii Deficiency |
7.8% |
| Furuncle |
7.0% |
| Psoriatic Arthropathy |
6.2% |
| Hypertension |
3.9% |
| Atrial Fibrillation |
3.1% |
| Arthralgia |
1.6% |
| Arthritis |
1.6% |
| Cardioversion |
1.6% |
| Depression |
1.6% |
| Tuberculosis Skin Test Positive |
1.6% |
| Ankylosing Spondylitis |
0.8% |
| Bronchitis |
0.8% |
| Cerebrovascular Accident Prophylaxis |
0.8% |
| Contraception |
0.8% |
| Lower Respiratory Tract Infection |
0.8% |
|
| Kidney Infection |
9.5% |
| Abdominal Pain |
7.1% |
| Headache |
7.1% |
| Malaise |
7.1% |
| Rheumatoid Arthritis |
7.1% |
| Vasculitis |
7.1% |
| Blood Alkaline Phosphatase Increased |
4.8% |
| Drug Interaction |
4.8% |
| Furuncle |
4.8% |
| Hepatic Enzyme Increased |
4.8% |
| Pain |
4.8% |
| Transaminases Increased |
4.8% |
| Viiith Nerve Lesion |
4.8% |
| Visual Impairment |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Aplasia Pure Red Cell |
2.4% |
| Asthenia |
2.4% |
| Colitis |
2.4% |
| Dyspnoea |
2.4% |
| Epilepsy |
2.4% |
|
